← Back to all trials
Completed
NCT07875283
Analgesia After Endoscopic Sleeve Gastroplasty
Conditions: Sleeve, Postoperative Pain, Obese Adult Male
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 100
Sponsor: American Hospital of Paris
Location: American Hospital of Paris Neuilly-sur-Seine
Summary
Endoscopic sleeve gastroplasty (ESG) is a new mini-invasive technique proposed to treat obesity (1-5). According to the endoscopic procedure compared to videolaparoscopy, this technique is supposed less painful and provide a reduction in postoperative complications (6-7). There are rare informations about the influence of ESG on postoperative painful (8). In this observational pilot study, the investigators prospectively assessed the postoperative analgesia concerns for this recent technique.
The authors evaluated the pain relief, including morphine consumption, pain and satisfaction scores and morbidity following a new endoscopic sleeve gastroplasty scheduled on the first 100 consecutive patients
Eligibility Criteria
Inclusion Criteria:
Endoscopic sleeve gastroplasty Obesity adult patient
Exclusion Criteria:
previous bariatric surgery (Kuzmack gastric band, sleeve or bypass) patient older less 18 years
Source: ClinicalTrials.gov (NCT07875283). StuddyBuddy aggregates publicly available trial information.